Kongressthemen As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow.
That's why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your definitive platform focused on the 2.0, next generation innovations in cell therapies.
Kongressorganizer (PCO) Hanson Wade
Anmerkungen Speakers: Leah Sibener Co-Founder, Head of Therapeutic Discovery 3T Biosciences, Blake Aftab Chief Scientific Officer Adicet Bio, Jak Knowles Chief Executive Officer Affini-T Therapeutics, Eric Von Hofe Chief Executive Officer AffyImmune and more.